Skip to main content

Latest SEC Filings — Page 136

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

AmpliTech Provides 2026 Outlook, $17M Backlog, and Tier-1 RFP Update
Form 8-KAMPG · Form 8-K · 2026-08-17
Principal Stockholder to Sell 20.5M Shares; Company to Repurchase $75M Concurrently
Form S-1ALH · Form S-1 · 2026-08-17
Enhertu Hits Primary Endpoint in First-Line HER2-Mutant Lung Cancer
ProForm 6-KAZN · Form 6-K · 2026-08-17
Cloudastructure Reports 164% Subscription Revenue Growth and Regains Nasdaq Compliance
Form 8-KCSAI · Form 8-K · 2026-08-17
AstraZeneca Halts Phase III eVOLVE-Lung02 Trial of Volrustomig in Metastatic NSCLC
ProForm 6-KAZN · Form 6-K · 2026-08-17
InspireMD Q2 Loss Widens to $14.3M; Cash Drops to $30.4M Amid Recall Fallout
Form 8-KNSPR · Form 8-K · 2026-08-17
Tagrisso + Orpathys Hits Both PFS and OS Endpoints in Phase III SAFFRON Trial
ProForm 6-KAZN · Form 6-K · 2026-08-17
Mobilicom Positions for U.S. Tariff-Driven Drone Demand Surge
Form 6-KMOB · Form 6-K · 2026-08-17
Madison Air to Acquire ebm-papst for €4.78B Enterprise Value, Backed by €1.3B Equity Commitment
ProForm 8-KMAIR · Form 8-K · 2026-08-17
Santacruz Silver Q2 2026: Revenue Up 55%, But One-Time Tax Hit Slashes Net Income
Form 6-KSCZM · Form 6-K · 2026-08-17
BitFuFu Q2 Revenue Plunges 63% to $42.8M, Swings to $20.5M Net Loss
ProForm 6-KFUFU · Form 6-K · 2026-08-17
MicroVision Prices $17M Offering at $2.50/Share with Warrants
ProForm 424B5MVIS · Form 424B5 · 2026-08-17
Enovix CEO Raj Talluri Steps Down; CFO Ryan Benton Takes Interim Helm, T.J. Rodgers Becomes Executive Chairman
ProForm 8-KENVX · Form 8-K · 2026-08-17
Third FDA Form 483 in Two Months Hits Dr. Reddy's
ProForm 6-KRDY · Form 6-K · 2026-08-17
Callan JMB Sets $2.10 Conversion Price and $2M Cash for Reger Oil Deal, Adds 15% Equity Plan
ProForm PRER14CCJMB · Form PRER14C · 2026-08-17
Prairie Operating Reports Strong Q2, Updates Guidance, and Amends Credit Facility
ProForm 8-KPROP · Form 8-K · 2026-08-17
XCF Global Q2 2026: Revenue Collapses 89%, Going Concern Doubt Reiterated, $238M Working Capital Deficit
ProForm 10-QSAFX · Form 10-Q · 2026-08-17
H World Q2 Revenue Up 10.8%, Raises Guidance, Announces $2.5B Return Plan
Form 6-KHTHT · Form 6-K · 2026-08-17
ORPATHYS plus TAGRISSO hits both PFS and OS endpoints in global Phase III SAFFRON trial
ProForm 6-KHCM · Form 6-K · 2026-08-17
FDCTech Q2 Revenue Jumps 222% to $17.5M; Reverse Split and Preferred Conversion Reshape Capital Structure
ProForm 10-QFDCT · Form 10-Q · 2026-08-17
Foresite Capital Reveals 14.5% Stake in Alumis Following IPO
Form SCHEDULE 13DALMS · Form SCHEDULE 13D · 2026-08-17
CEO Seto Wai Yue Buys 320,000 More Shares at $3.75, Lifting Stake to 32.99%
Form SCHEDULE 13D/ATDIC · Form SCHEDULE 13D/A · 2026-08-17
DataMeds AI Reports $26.1M Loss, Going Concern Doubt, and Nasdaq Equity Deficiency
ProForm 10-QMEDS · Form 10-Q · 2026-08-17
Centene CFO Andrew Asher to Retire; Christopher Neczypor Named Successor
Form 8-KCNC · Form 8-K · 2026-08-17
Interactive Strength Seeks Shareholder Approval for Massive Dilution and Reverse Split
ProForm DEF 14ATRNR · Form DEF 14A · 2026-08-17
Endeavour Silver Suspends Terronera Mine Operations Amid Illegal Blockade
ProForm 6-KEXK · Form 6-K · 2026-08-17
Valion Bio Terminates CEO, Appoints COO, and Secures $3M from Activist Investor
ProForm 8-KVBIO · Form 8-K · 2026-08-17
TTM Technologies Signs Definitive $1.1B All-Cash Deal to Acquire Epiq Solutions
ProForm 8-KTTMI · Form 8-K · 2026-08-17
Q2 Loss Narrows Dramatically, But Going Concern & Control Weaknesses Persist Amidst Crucial Financing
ProForm 10-QEMAT · Form 10-Q · 2026-08-17
CEO Seto Wai Yue Adds $1.2M Stake in Dreamland at $3.75, Now Holds 32.99%
ProForm 4/ATDIC · Form 4/A · 2026-08-17